Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             35 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Activated factor VIII-mimicking effect by emicizumab on thrombus formation in type 2N von Willebrand disease under high shear flow conditions Yaoi, Hiroaki

198 C p. 7-16
artikel
2 Association of anticoagulation use with SARS-CoV2 detection Kavecansky, Juraj

198 C p. 99-102
artikel
3 Biomarker association with cardiovascular disease and mortality – The role of fibrinogen. A report from the NHANES study Pieters, Marlien

198 C p. 182-189
artikel
4 Challenging anticoagulation cases: A case of acute pulmonary embolism in a patient with chronic thrombocytopenia de Wit, Kerstin

198 C p. 83-85
artikel
5 Deep vein thrombosis in a tertiary hospital from Ethiopia Amare, Hiwot

198 C p. 17-18
artikel
6 Discordance in activated partial thromboplastin time and anti-factor Xa levels in COVID-19 patients on heparin therapy Lawlor, Matthew

198 C p. 79-82
artikel
7 Editorial Board
198 C p. IFC
artikel
8 Elevated anti-human factor Xa activity in rabbit and rodent plasma: Implications for preclinical assessment of human factor X in animal models of hemostasis Verhoef, Daniël

198 C p. 154-162
artikel
9 Glycation and acetylation sites on fibrinogen in plasma fibrin clot of patients with type 2 diabetes: Effects of low-dose acetylsalicylic acid Bryk, Agata Hanna

198 C p. 93-98
artikel
10 How significant is the antifibrinolytic effect of lipoprotein(a) for blood clot lysis? Rijken, Dingeman C.

198 C p. 210-212
artikel
11 Immature platelet dynamics correlate with ADAMTS13 deficiency and predict therapy response in immune-mediated thrombotic thrombocytopenic purpura Zhu, Meng-Lei

198 C p. 72-78
artikel
12 Impact of uric acid on immature platelet fraction in patients undergoing percutaneous coronary intervention Nardin, Matteo

198 C p. 171-181
artikel
13 Incidence of inhibitor development in PUPs with severe Haemophilia A in the CEE region between 2005 and 2015 Blatný, Jan

198 C p. 196-203
artikel
14 Incidence of symptomatic venous thromboembolism following hospitalization for coronavirus disease 2019: Prospective results from a multi-center study Rashidi, Farid

198 C p. 135-138
artikel
15 Influence of low body weight on long-term clinical outcomes in patients with venous thromboembolism: From the COMMAND VTE registry Kaneda, Kazuhisa

198 C p. 26-33
artikel
16 Is chemoprophylaxis required after total knee and total hip arthroplasty in the Asian population? A systematic review and network meta-analysis Xu, Sheng

198 C p. 86-92
artikel
17 Links between thrombosis and inflammation in traumatic brain injury Hubbard, W. Brad

198 C p. 62-71
artikel
18 Low molecular weight heparin and 28-day mortality among patients with coronavirus disease 2019: A cohort study in the early epidemic era Qin, Wei

198 C p. 19-22
artikel
19 Opinion and practice survey about the use of prognostic models in acute pulmonary embolism Elias, Antoine

198 C p. 40-48
artikel
20 Platelet electrical resistance for measuring platelet activation and adhesion in human health and disease Griffiths, Travis M.

198 C p. 204-209
artikel
21 Possible immune regulation mechanisms for the progression of chronic thromboembolic pulmonary hypertension Miao, Ran

198 C p. 122-131
artikel
22 Prevalence of definite antiphospholipid syndrome in carriers of the JAK2 V617F mutation Janjetovic, Snjezana

198 C p. 55-61
artikel
23 Primary antiphospholipid syndrome revealed by acute myocardial infarction in young adults: a prospective observational study Chezel, Julie

198 C p. 151-153
artikel
24 Pulmonary embolism in COVID-19 patients: prevalence, predictors and clinical outcome Scudiero, Fernando

198 C p. 34-39
artikel
25 P2Y12 inhibitor monotherapy and dual antiplatelet therapy after percutaneous coronary intervention: An updated meta-analysis of randomized trials Jin, Yao

198 C p. 115-121
artikel
26 Safety and effectiveness of apixaban compared with warfarin among clinically-relevant subgroups of venous thromboembolism patients in the United States Medicare population Guo, Jennifer D.

198 C p. 163-170
artikel
27 The novel mutation p.Asp315Tyr causes severe hemophilia B by impairing coagulation factor IX expression Lu, Zhengjing

198 C p. 23-25
artikel
28 Thrombotic antiphospholipid syndrome: A practical guide to diagnosis and management Sayar, Zara

198 C p. 213-221
artikel
29 Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease Ciavarella, Alessandro

198 C p. 139-150
artikel
30 Type 2N von Willebrand disease: Is it always a recessive trait? Woods, Adriana Inés

198 C p. 49-51
artikel
31 Use and outcomes of prothrombin complex concentrate for factor Xa inhibitor-associated bleeding Frank, Annabel K.

198 C p. 132-134
artikel
32 Using oral anticoagulants among chronic kidney disease patients to prevent recurrent venous thromboembolism: A systematic review and meta-analysis Alhousani, Mohammad

198 C p. 103-114
artikel
33 Venous thromboembolism in renal transplant recipients: Results of Venous thromboEmbolism in renal Transplant Recipients- Italian Study - VETRIS Poli, Daniela

198 C p. 52-54
artikel
34 Von Willebrand factor in aortic or mitral valve stenosis and bleeding after heart valve surgery Mazur, Piotr

198 C p. 190-195
artikel
35 Weight-adjusted tinzaparin for venous thromboembolism prophylaxis in bariatric surgery patients weighing 160 kg or more Li, A.

198 C p. 1-6
artikel
                             35 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland